National Immunotherapy Cancer Research Foundation Inc

Analysis

National Immunotherapy Cancer Research Foundation Inc is a registered charity in United States, based in Flemington, NJ. It received its IRS tax-exemption ruling in December 1990, 36 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, National Immunotherapy Cancer Research Foundation Inc reported income of $151k and spending of $98k, leaving 35% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income fell from $330k to $151k (-54%), an average of -18% a year. The sharpest change came in the year to December 2023, when income rose by 3324%. Over the whole period it spent 270% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Immunotherapy Cancer Research Foundation Inc sits at the 35th percentile: it is larger than about 35% of them. Against every charity in United States with reported income it ranks in the 47th percentile, and in the 55th percentile within NJ. Charities of a similar size with the same main cause include The Rotary Club of Northern Calif Foundation Against Substance Abuse ($151k), R Baby Foundation Inc ($151k) and Foundation for Research and Advocacy for Muscle Pain Education ($151k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 107% of the total. At year end it held assets of $1.1m against liabilities of $462k, net assets of $590k.